Doctor's Bio
Dr. Jonathan Colasanti, MD, MSPH is an Assistant Professor of Medicine (Infectious Diseases) and Global Health (Rollins School of Public Health) at Emory University in Atlanta, Georgia. He completed medical school and a Master’s in Public Health at the University of Miami. He completed his Internal Medicine and Global Health Residency at the University of Miami and his Infectious Diseases fellowship at Emory University.
Jonathan developed a passion for HIV in high school and has dedicated himself to the field ever since. He has experience treating PLHIV in Miami, Atlanta, Peru, Nicaragua and Ethiopia, giving him a global perspective of HIV treatment and care. His clinical and research interests focus on the delivery of HIV care to vulnerable populations, across the spectrum of the HIV care continuum. In his research, he seeks to bridge the implementation gap in order to improve the delivery of HIV care, by addressing socio-behavioral, biomedical, and systems-level barriers. In addition to his Atlanta-based work, he serves on the U.S. advisory board for a Nicaraguan NGO that strives to improve the delivery of primary health care in Nicaragua through a community health worker model.
Board Certifications
American Board of Internal Medicine
Affiliations
Emory
Education & Training
- Medical School: University of Miami Miller School of Medicine
- Internship: University of Miami - Jackson Health System
- Residency: University of Miami/Jackson Memorial Hospital
Fellowships
Emory University School of Medicine
Locations and Directions
Ponce De Leon Center
Phone: (404) 616-2440
Location:
341 Ponce De Leon Ave. NE
Atlanta, GA 30308
Publications
- Long-acting cabotegravir/rilpivirine, lenacapavir, and ibalizumab use among persons with HIV-1 viremia at a Ryan White-funded clinic in the urban U.S. South.
Colasanti JA, Aldredge A, Niles-Carnes LV, Ochieng E, Pareek P, Robinson V, Anderson E, Castaneda M, Spralling H, Smith BL, Sumitani J, Paul Leue E, Moran CA, Lora M, Armstrong WS, Collins LF
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2025;
PMID: 40747944 - Comparing interest in thigh administration of long-acting cabotegravir/rilpivirine among hypothetical users, early adopters and trial participants with experience.
Collins LF, Christopoulos KA, McNulty MC, Colasanti JA
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2025;
PMID: 40560533 - Statins for primary prevention of cardiovascular events in people with HIV: target trial and modelling study.
Yebyo HG, Guenthard HF, Rehfuess EA, Serra N, Haile SR, Senn O, Lucas GM, Langselius O, Thorne JE, Marconi VC, Coburn SB, Lang R, Colasanti JA, Silverberg MJ, Napravnik S, Loutfy M, Karris M, Sterling TR, Burkholder GA, Althoff KN, Puhan MA
BMJ medicine. 2025;4(1):e001132.
PMID: 40395649 - Project RETAIN: Providing Integrated Care for People With HIV Who Use Cocaine.
Metsch LR, Feaster DJ, Gooden LK, Pan Y, Parish CL, Waldrop D, Rodriguez A, Colasanti JA, Armstrong WS, Root C, Del Rio C, Castellón PC, Miller M, Pereyra MR
Open forum infectious diseases. 2025;12(4):ofaf104.
PMID: 40276720 - Changes in the prevalence of non-AIDS conditions among hospitalized persons with HIV in the United States and Canada, 2008-2018.
Davy-Mendez T, Napravnik S, Hogan BC, Eron JJ, Gebo KA, Althoff KN, Moore RD, Silverberg MJ, Horberg MA, Gill MJ, Colasanti JA, Nijhawan A, Karris MY, Klein MB, Lang R, Lesko CR, Yendewa GA, Kirk GD, McGinnis KA, Berry SA,
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2025;
PMID: 40178532 - Identifying preferred program delivery attributes for long-acting injectable cabotegravir-rilpvirine in three U.S. HIV clinics: A discrete choice experiment.
Gutierrez JI, Montgomery ET, Dilworth SE, McNulty MC, Colasanti JA, Johnson MO, Koester KA, Sauceda JA, Erguera XA, Dance K, Tsuzuki MD, Hickey MD, Kerkhoff AD, Neilands TB, Eshun-Wilson I, Geng E, Christopoulos KA,
Journal of acquired immune deficiency syndromes (1999). 2025;
PMID: 40079720 - Enhancing Hepatitis B Virus Vaccine Uptake and Immunity Through Long-Acting Antiretroviral Therapy Programmatic Synergy in the US South.
Ochieng E, Robinson V, Anderson E, Niles-Carnes L, Smith BL, Armstrong WS, Lora M, Colasanti JA, Collins LF
Open forum infectious diseases. 2025;12(3):ofaf096.
PMID: 40046888 - Opioid risk-reduction strategies for people with HIV on chronic opioid therapy: A qualitative study of patient perspectives.
Lunze K, Carroll JJ, Ahuja N, Lira MC, Tsui JI, Ventura A, Colasanti JA, Liebschutz JM, Del Rio C, Samet JH
SSM. Mental health. 2024;
PMID: 39990723 - Policy Recommendations to Support Equitable Access to Long-Acting Injectables for Human Immunodeficiency Virus Prevention and Treatment: A Policy Paper of the Infectious Diseases Society of America and the HIV Medicine Association.
Marcus JL, Weddle A, Kelley CF, Agwu A, Montalvo S, Sherman E, Vijayan T, Gutierrez J, Hickey MD, Dilworth SE, Krakower D, Davis TL, Collins LF, McNulty MC, Colasanti JA, Christopoulos KA
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2025;
PMID: 39873495 - Missed and Delayed Diagnoses of Acute Human Immunodeficiency Virus (HIV) Infection in a Southern Opt-Out HIV Testing Environment Without Reflex HIV RNA Testing.
Gruber SF, Wilber EP, Smith B, Rebolledo PA, Colasanti JA, Iytha R, Schwinne M, Robichaux C, Lora MH
Open forum infectious diseases. 2025;12(1):ofae684.
PMID: 39829638
PLANNING
PREPARING FOR YOUR VISIT
Whether you’re a patient or you’re visiting one, a little planning beforehand can make your visit to Grady easier and more comfortable. Here, you’ll find everything you need to prepare for your visit, including an appointment checklist, admissions information, dining options, and much more.